Lung squamous cell carcinoma recurrent: Which Medications Are Safest? (18 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18 medications are used for Lung squamous cell carcinoma recurrent, with 103 combined adverse event reports. The most reported drugs for Lung squamous cell carcinoma recurrent are PEMBROLIZUMAB and PACLITAXEL.
103
Total Reports
18
Drugs Used
All Medications for Lung squamous cell carcinoma recurrent Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| PEMBROLIZUMAB | KEYTRUDA | 36 | 15,543 | 35,472 | 18.6% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 25 | 12,030 | 31,638 | 15.6% |
| CARBOPLATIN | Carboplatin | 24 | 12,544 | 35,869 | 14.9% |
| DOCETAXEL | Docetaxel | 20 | 6,068 | 13,463 | 9.3% |
| RAMUCIRUMAB | CYRAMZA | 18 | 1,444 | 2,066 | 27.0% |
| CISPLATIN | CISplatin | 11 | 8,387 | 17,469 | 17.7% |
| NECITUMUMAB | Portrazza | 11 | 69 | 131 | 18.8% |
| GEMCITABINE | Gemcitabine | 9 | 5,142 | 12,268 | 16.4% |
| NIVOLUMAB | OPDIVO | 9 | 23,086 | 36,530 | 26.3% |